Literature DB >> 27872257

Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis.

Gabriëlla A M Blokland1,2,3, Raquelle I Mesholam-Gately2,4,5, Timothea Toulopoulou6,7,8, Elisabetta C Del Re2,9, Max Lam10, Lynn E DeLisi2,9, Gary Donohoe11,12, James T R Walters13, Larry J Seidman2,4,5, Tracey L Petryshen1,2,3.   

Abstract

Schizophrenia is characterized by neuropsychological deficits across many cognitive domains. Cognitive phenotypes with high heritability and genetic overlap with schizophrenia liability can help elucidate the mechanisms leading from genes to psychopathology. We performed a meta-analysis of 170 published twin and family heritability studies of >800 000 nonpsychiatric and schizophrenia subjects to accurately estimate heritability across many neuropsychological tests and cognitive domains. The proportion of total variance of each phenotype due to additive genetic effects (A), shared environment (C), and unshared environment and error (E), was calculated by averaging A, C, and E estimates across studies and weighting by sample size. Heritability ranged across phenotypes, likely due to differences in genetic and environmental effects, with the highest heritability for General Cognitive Ability (32%-67%), Verbal Ability (43%-72%), Visuospatial Ability (20%-80%), and Attention/Processing Speed (28%-74%), while the lowest heritability was observed for Executive Function (20%-40%). These results confirm that many cognitive phenotypes are under strong genetic influences. Heritability estimates were comparable in nonpsychiatric and schizophrenia samples, suggesting that environmental factors and illness-related moderators (eg, medication) do not substantially decrease heritability in schizophrenia samples, and that genetic studies in schizophrenia samples are informative for elucidating the genetic basis of cognitive deficits. Substantial genetic overlap between cognitive phenotypes and schizophrenia liability (average rg = -.58) in twin studies supports partially shared genetic etiology. It will be important to conduct comparative studies in well-powered samples to determine whether the same or different genes and genetic variants influence cognition in schizophrenia patients and the general population.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cognition; endophenotypes; heritability; meta-analysis; neuropsychology; twin study

Mesh:

Year:  2017        PMID: 27872257      PMCID: PMC5472145          DOI: 10.1093/schbul/sbw146

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  87 in total

1.  Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.

Authors:  David T Liebers; Mehdi Pirooznia; Fayaz Seiffudin; Katherine L Musliner; Peter P Zandi; Fernando S Goes
Journal:  Schizophr Bull       Date:  2016-02-12       Impact factor: 9.306

2.  Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).

Authors:  Keith H Nuechterlein; Michael F Green; Monica E Calkins; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Gregory A Light; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Res       Date:  2015-03-04       Impact factor: 4.939

3.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

4.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

5.  Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications.

Authors:  Junghee Lee; Michael F Green; Monica E Calkins; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Gregory A Light; Keith H Nuechterlein; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Res       Date:  2014-09-22       Impact factor: 4.939

6.  Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Richard S E Keefe; John A Sweeney; Hongbin Gu; Robert M Hamer; Diana O Perkins; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

7.  Smoking improves divided attention in schizophrenia.

Authors:  Eike Ahlers; Eric Hahn; Thi Minh Tam Ta; Elnaz Goudarzi; Michael Dettling; Andres H Neuhaus
Journal:  Psychopharmacology (Berl)       Date:  2014-03-26       Impact factor: 4.530

8.  Genome-wide association study identifies five new schizophrenia loci.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

9.  Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).

Authors:  G Davies; N Armstrong; J C Bis; J Bressler; V Chouraki; S Giddaluru; E Hofer; C A Ibrahim-Verbaas; M Kirin; J Lahti; S J van der Lee; S Le Hellard; T Liu; R E Marioni; C Oldmeadow; I Postmus; A V Smith; J A Smith; A Thalamuthu; R Thomson; V Vitart; J Wang; L Yu; L Zgaga; W Zhao; R Boxall; S E Harris; W D Hill; D C Liewald; M Luciano; H Adams; D Ames; N Amin; P Amouyel; A A Assareh; R Au; J T Becker; A Beiser; C Berr; L Bertram; E Boerwinkle; B M Buckley; H Campbell; J Corley; P L De Jager; C Dufouil; J G Eriksson; T Espeseth; J D Faul; I Ford; R F Gottesman; M E Griswold; V Gudnason; T B Harris; G Heiss; A Hofman; E G Holliday; J Huffman; S L R Kardia; N Kochan; D S Knopman; J B Kwok; J-C Lambert; T Lee; G Li; S-C Li; M Loitfelder; O L Lopez; A J Lundervold; A Lundqvist; K A Mather; S S Mirza; L Nyberg; B A Oostra; A Palotie; G Papenberg; A Pattie; K Petrovic; O Polasek; B M Psaty; P Redmond; S Reppermund; J I Rotter; H Schmidt; M Schuur; P W Schofield; R J Scott; V M Steen; D J Stott; J C van Swieten; K D Taylor; J Trollor; S Trompet; A G Uitterlinden; G Weinstein; E Widen; B G Windham; J W Jukema; A F Wright; M J Wright; Q Yang; H Amieva; J R Attia; D A Bennett; H Brodaty; A J M de Craen; C Hayward; M A Ikram; U Lindenberger; L-G Nilsson; D J Porteous; K Räikkönen; I Reinvang; I Rudan; P S Sachdev; R Schmidt; P R Schofield; V Srikanth; J M Starr; S T Turner; D R Weir; J F Wilson; C van Duijn; L Launer; A L Fitzpatrick; S Seshadri; T H Mosley; I J Deary
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

10.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

View more
  18 in total

Review 1.  Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.

Authors:  Maria R Dauvermann; Graham Lee; Neil Dawson
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

2.  Social Cognition, Language, and Social Behavior in 7-Year-Old Children at Familial High-Risk of Developing Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7-A Population-Based Cohort Study.

Authors:  Camilla Jerlang Christiani; Jens R M Jepsen; Anne Thorup; Nicoline Hemager; Ditte Ellersgaard; Katrine S Spang; Birgitte K Burton; Maja Gregersen; Anne Søndergaard; Aja N Greve; Ditte L Gantriis; Gry Poulsen; Md Jamal Uddin; Larry J Seidman; Ole Mors; Kerstin J Plessen; Merete Nordentoft
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

3.  Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.

Authors:  Jun Konishi; Elisabetta C Del Re; Sylvain Bouix; Gabriëlla A M Blokland; Raquelle Mesholam-Gately; Kristen Woodberry; Margaret Niznikiewicz; Jill Goldstein; Yoshio Hirayasu; Tracey L Petryshen; Larry J Seidman; Martha E Shenton; Robert W McCarley
Journal:  Brain Imaging Behav       Date:  2018-08       Impact factor: 3.978

4.  Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.

Authors:  Nicoline Hemager; Kerstin J Plessen; Anne Thorup; Camilla Christiani; Ditte Ellersgaard; Katrine Søborg Spang; Birgitte Klee Burton; Maja Gregersen; Anne Søndergaard; Aja Neergaard Greve; Ditte Lou Gantriis; Gry Poulsen; Larry J Seidman; Ole Mors; Merete Nordentoft; Jens Richardt Møllegaard Jepsen
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

5.  A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.

Authors:  Ellen Kure Fischer; Antonio Drago
Journal:  J Neural Transm (Vienna)       Date:  2017-05-05       Impact factor: 3.575

6.  Deviation from expected cognitive ability across psychotic disorders.

Authors:  W C Hochberger; T Combs; J L Reilly; J R Bishop; R S E Keefe; B A Clementz; M S Keshavan; G D Pearlson; C A Tamminga; S K Hill; J A Sweeney
Journal:  Schizophr Res       Date:  2017-05-22       Impact factor: 4.939

7.  Cortical Gyrification, Psychotic-Like Experiences, and Cognitive Performance in Nonclinical Subjects.

Authors:  Ulrika Evermann; Christian Gaser; Bianca Besteher; Kerstin Langbein; Igor Nenadić
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

8.  Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.

Authors:  Soichiro Nakahara; Sarah Medland; Jessica A Turner; Vince D Calhoun; Kelvin O Lim; Bryon A Mueller; Juan R Bustillo; Daniel S O'Leary; Jatin G Vaidya; Sarah McEwen; James Voyvodic; Aysenil Belger; Daniel H Mathalon; Judith M Ford; Guia Guffanti; Fabio Macciardi; Steven G Potkin; Theo G M van Erp
Journal:  Schizophr Res       Date:  2018-06-12       Impact factor: 4.939

9.  Genetic influence on cognitive development between childhood and adulthood.

Authors:  Josephine Mollon; Emma E M Knowles; Samuel R Mathias; Ruben Gur; Juan Manuel Peralta; Daniel J Weiner; Elise B Robinson; Raquel E Gur; John Blangero; Laura Almasy; David C Glahn
Journal:  Mol Psychiatry       Date:  2018-10-19       Impact factor: 15.992

10.  The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project.

Authors:  Gabriëlla A M Blokland; Elisabetta C Del Re; Raquelle I Mesholam-Gately; Jorge Jovicich; Joey W Trampush; Matcheri S Keshavan; Lynn E DeLisi; James T R Walters; Jessica A Turner; Anil K Malhotra; Todd Lencz; Martha E Shenton; Aristotle N Voineskos; Dan Rujescu; Ina Giegling; René S Kahn; Joshua L Roffman; Daphne J Holt; Stefan Ehrlich; Zora Kikinis; Paola Dazzan; Robin M Murray; Marta Di Forti; Jimmy Lee; Kang Sim; Max Lam; Rick P F Wolthusen; Sonja M C de Zwarte; Esther Walton; Donna Cosgrove; Sinead Kelly; Nasim Maleki; Lisa Osiecki; Marco M Picchioni; Elvira Bramon; Manuela Russo; Anthony S David; Valeria Mondelli; Antje A T S Reinders; M Aurora Falcone; Annette M Hartmann; Bettina Konte; Derek W Morris; Michael Gill; Aiden P Corvin; Wiepke Cahn; New Fei Ho; Jian Jun Liu; Richard S E Keefe; Randy L Gollub; Dara S Manoach; Vince D Calhoun; S Charles Schulz; Scott R Sponheim; Donald C Goff; Stephen L Buka; Sara Cherkerzian; Heidi W Thermenos; Marek Kubicki; Paul G Nestor; Erin W Dickie; Evangelos Vassos; Simone Ciufolini; Tiago Reis Marques; Nicolas A Crossley; Shaun M Purcell; Jordan W Smoller; Neeltje E M van Haren; Timothea Toulopoulou; Gary Donohoe; Jill M Goldstein; Larry J Seidman; Robert W McCarley; Tracey L Petryshen
Journal:  Schizophr Res       Date:  2017-10-03       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.